Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StemCor Systems was a medical technology company that specialized in developing innovative devices for bone marrow aspiration and stem cell harvesting. Its flagship product, the Marrow-Cor Bone Marrow Aspiration System, was designed to provide a less invasive and more efficient method for obtaining high-quality bone marrow and progenitor cells compared to traditional needles. The technology aimed to improve clinical outcomes in orthopedic, vascular, and cardiac regenerative medicine by ensuring a high concentration of regenerative cells. Founded in 2008 and based in Menlo Park, California, the company was backed by prominent venture capital firms including Kleiner Perkins and IVP. In May 2011, StemCor Systems was acquired by Stryker Corporation to enhance its orthobiologics and regenerative medicine portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StemCor Systems.